|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
DRUG INTERACTIONS |
From the Department of Clinical Pharmacology and Therapeutics, Oita Medical University, Oita, Japan (Dr. Morimoto, Dr. Tsutsumi, Dr. Imai, Dr. Nakano) and the Clinical Pharmacology Center, Oita Medical University Hospital, Oita, Japan (Dr. Kotegawa, Dr. Ohtani, Dr, Nakano).
The objective of this study was to investigate the effect of St. John's wort (SJW, Hypericum perforatum) on the pharmacokinetics of theophylline in healthy volunteers. Twelve healthy Japanese male volunteers participated in this randomized, open-labeled, crossover study. The subjects took an SJW caplet (300 mg) three times a day for 15 days. On day 14, they received a single oral dose of 400 mg of theophylline. They took the same dose of theophylline without SJW treatment on another occasion. Plasma and urine samples were obtained during a 48-hour period after theophylline administration. Theophylline concentrations in plasma and urine, as well as the major metabolites (13U, 1U, 3X) in urine, were measured. SJW caused no significant changes in the pharmacokinetics of theophylline in plasma. SJW administration tended to increase the ratio of 1U/the total amount excreted in urine. However, no changes in the ratio of unchanged theophylline, 13U, and 3X were observed. It is unlikely that the effect of 15 days of treatment with SJW on CYPs is sufficient to cause a change in plasma theophylline concentrations.
Key Words: St. John's wort theophylline drug metabolism pharmacokinetics herb-drug interactions
Address for reprints: Tsutomu Kotegawa, MD, PhD, Clinical Pharmacology Center, Oita Medical University Hospital, Hasama-machi, Oita 879-5593, Japan.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
E. Mills, V. M Montori, P. Wu, K. Gallicano, M. Clarke, and G. Guyatt Interaction of St John's wort with conventional drugs: systematic review of clinical trials BMJ, July 3, 2004; 329(7456): 27 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sparreboom, M. C. Cox, M. R. Acharya, and W. D. Figg Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents J. Clin. Oncol., June 15, 2004; 22(12): 2489 - 2503. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-S. Wang, B. Zhu, A. M. A. El-Aty, G. Zhou, Z. Li, J. Wu, G.-L. Chen, J. Liu, Z. R. Tang, W. An, et al. The Influence of St. John's Wort on CYP2C19 Activity with Respect to Genotype J. Clin. Pharmacol., June 1, 2004; 44(6): 577 - 581. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |